SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is currently under significant pressure as the company faces a series of high-profile legal challenges regarding social media addiction and child safety, with recent court rulings sparking widespread community concern over potential financial liabilities and long-term business model changes. Investors are actively debating the stock's future amid these mounting legal hurdles, conflicting reports about executive compensation targets, and ongoing market volatility driven by broader geopolitical uncertainties.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is trending as investors grapple with significant volatility and a downward trend in share price, leading to heated community debates over the platform's long-term commercial viability and the prevalence of bot activity. While some traders view the current levels as a potential buy-the-dip opportunity or a setup for a short squeeze, many are expressing frustration over management's handling of the platform and the stock's ongoing detachment from broader market gains.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech100 is drawing significant investor interest as a proxy for the upcoming SpaceX IPO, with community members actively comparing its concentrated exposure in SpaceX and Anthropic to other high-valuation funds. Traders are closely monitoring volume and potential short-squeeze dynamics, debating whether the current price represents an attractive entry relative to net asset value or if it is currently overextended.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Cipher Mining Inc

Cipher Mining is trending as investors weigh the company's strategic pivot toward AI-focused data center leases against broader market volatility and geopolitical concerns. While some community members remain frustrated by the stock's lack of momentum and recent insider selling, others are actively buying the dip, citing long-term growth potential tied to major hyperscaler contracts and institutional interest in the sector.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences is experiencing significant market volatility following interim Phase 1 data for its obesity candidate, WVE-007, which has sparked intense debate over the efficacy of its 'quality weight loss' approach compared to established GLP-1 incumbents. While the company faces skepticism regarding its patient baseline metrics and a recent stock offering, the community remains divided between investors betting on a long-term rebound based on the drug's muscle-preserving potential and those concerned about the company's valuation and clinical strategy.

Maase, Inc. engages in the provision of intelligent technology-driven family and enterprise services. It operates through the following business segments: Insurance Agency and Wealth Management. The Insurance Agency segment involves in providing agency services for distributing life and non-life insurance products on behalf of insurance companies. The Wealth Management segment offers financial advisory, investment planning, and asset management services for individuals, families, and corporate clients, utilizing data-driven insights and digital platforms to optimize financial outcomes. The company was founded by Hai Feng Yu on August 6, 2018, and is headquartered in Guangzhou, China.

Maase Inc. - Ordinary Shares - Class A

Highest Performances Holdings Inc. - ADR

MAAS is generating significant buzz as investors interpret its recent string of acquisitions, including smart-charging robotics and biotech-focused assets, as a strategic pivot toward an AI-integrated infrastructure platform. Community discourse is heavily focused on the company's potential to re-rate from a niche small-cap operator into a diversified technology ecosystem, with many participants debating the stock's low-float setup and its capacity to execute across cross-sector growth verticals.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is drawing heavy community attention as investors debate the sustainability of its 'TONMYA' fibromyalgia drug launch amid ongoing share dilution and repeated reverse-split concerns. While some bulls are encouraged by rising prescription data and insider purchases by CEO Seth Lederman, bears are actively pointing to significant cash burn and a declining share price as evidence of deeper fundamental trouble.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending amidst intense community debate regarding the company's future in light of escalating geopolitical tensions in the Middle East and concerns over potential military involvement. Investors and critics are actively parsing mixed reports on diplomatic negotiations, debating the impact of the ongoing conflict on energy markets, and questioning the company's fundamental stability as partisan discourse intensifies.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending as investors weigh strong data center growth and CPU price hikes against broader market uncertainty fueled by geopolitical tensions. While technical traders monitor key support and resistance levels, the community remains divided between those seeing a long-term AI juggernaut and those fearing the stock is caught in a wider market sell-off.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiak Sciences shares surged following positive late-stage GLOW2 study results for its eye drug, Zenkuda, which demonstrated statistically significant efficacy in treating diabetic retinopathy. The community is actively debating the stock's potential for a short squeeze due to high short interest, while investors look for further updates on pivotal trial design, cash runway, and potential interest from major pharmaceutical companies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Up 9.3% - Should You Buy?

Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Up 9.3% - Here's What Happened...

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Average Rating of "Hold" by Brokerages

Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Get Free Report) have received an average recommendation of "Hold" from the eighteen analysts that are presently covering the firm, Marketbeat...

Rocket Pharmaceuticals (NASDAQ:RCKT) Trading Down 4.4% - Here's What Happened

Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Down 4.4% - Time to Sell...

Rocket Pharmaceuticals (NASDAQ:RCKT) Trading Down 4.8% - Should You Sell?

Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Down 4.8% - Here's Why...

Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Up 5.4% - What's Next?

Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Up 5.4% - Time to Buy...

Rocket Pharmaceuticals (NASDAQ:RCKT) Cut to Sell at Wall Street Zen

Wall Street Zen downgraded Rocket Pharmaceuticals from a "hold" rating to a "sell" rating in a research note on Sunday...

The Goldman Sachs Group Forecasts Strong Price Appreciation for Rocket Pharmaceuticals (NASDAQ:RCKT) Stock

The Goldman Sachs Group lifted their price target on shares of Rocket Pharmaceuticals from $2.00 to $3.00 and gave the stock a "sell" rating in a research note on Monday...

Brokers Set Expectations for RCKT FY2026 Earnings

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) - Analysts at Lifesci Capital issued their FY2026 earnings estimates for shares of Rocket Pharmaceuticals in a report released on Thursday...

Lifesci Capital Upgrades Rocket Pharmaceuticals (NASDAQ:RCKT) to Strong-Buy

Lifesci Capital upgraded Rocket Pharmaceuticals to a "strong-buy" rating in a research report on Thursday...

Rocket Pharmaceuticals (NASDAQ:RCKT) Upgraded to "Hold" at Wall Street Zen

Wall Street Zen upgraded shares of Rocket Pharmaceuticals from a "strong sell" rating to a "hold" rating in a research note on Saturday...

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. Its clinical program is an LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. The company was founded on July 7, 1999 and is headquartered in Cranbury, NJ.

Rocket Pharmaceuticals Inc

ManoJaggarwal bullish call on $MU at $68.07

FinnessaurusFlex bullish call on $ASTS at $1.98

NeverFadeTheOracle bullish call on $SNDK at $41.95

stockwinner1966 bullish call on $USAS at $0.42

Celebrating the single best "called shot" of the year. This award honors a trade that combined timing with conviction, proving that market mastery is an art.

Stocktwits

Stocktwits Polls

Traders are closely tracking the March 28 deadline for an FDA decision, with most expecting news Friday after the market closes.

Heavy call buying and elevated implied volatility show traders betting big on a post-approval price surge.

Recent executive job postings are being interpreted as a bullish signal that the company is scaling up for commercial launch.

Investors are eyeing the $5 strike price as a potential catalyst for acceleration if delta hedging forces a massive breakout.

Aggressive accumulation is being noted around the $4.15 level as investors defend positions ahead of the weekend catalyst.

RCKT
Rocket Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest RCKT News

RCKTRocket Pharmaceuticals Inc